Although cardiac EF in Lmna DCM was significantly improved to ~ 35% upon Smad3 shRNA treatment, the median survival was not significantly extended, suggesting improved cardiac function does not always extend to prolonged animal survival. This evidence concerns the gene SMAD3 and familial dilated cardiomyopathy.